Last reviewed · How we verify

[14C]-ITI-1284

Intra-Cellular Therapies, Inc. · Phase 1 active Small molecule

[14C]-ITI-1284 is a Small molecule drug developed by Intra-Cellular Therapies, Inc.. It is currently in Phase 1 development.

At a glance

Generic name[14C]-ITI-1284
SponsorIntra-Cellular Therapies, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about [14C]-ITI-1284

What is [14C]-ITI-1284?

[14C]-ITI-1284 is a Small molecule drug developed by Intra-Cellular Therapies, Inc..

Who makes [14C]-ITI-1284?

[14C]-ITI-1284 is developed by Intra-Cellular Therapies, Inc. (see full Intra-Cellular Therapies, Inc. pipeline at /company/intra-cellular-therapies-inc).

What development phase is [14C]-ITI-1284 in?

[14C]-ITI-1284 is in Phase 1.

Related